United States

People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

22 Sep 2017
Change (% chg)

$0.15 (+4.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Dasu, Badri 

Mr. Badri N. Dasu is the Chief Engineering Officer of AcelRx Pharmaceuticals Inc. From December 2005 until September 2007, Mr. Dasu served as Vice President of Medical Device Engineering at Anesiva, Inc., a biopharmaceutical company. From March 2002 until December 2005, Mr. Dasu served as Vice President for Manufacturing and Device Development at AlgoRx Pharmaceuticals, Inc., an emerging pain management company, which merged with Corgentech Inc., a biotechnology company, in December 2005. From January 2000 until March 2002, Mr. Dasu served as Vice President of Manufacturing and Process Development at PowderJect Pharmaceuticals, a vaccine, drug and diagnostics delivery company that was acquired by Chiron Corporation in 2003 and later acquired by Novartis AG, a global healthcare and pharmaceutical company, in 2006. Previously, Mr. Dasu served in various capacities in process development at Metrika, Inc., a company focused on the manufacture and marketing of disposable diabetes monitoring products that was acquired by Bayer HealthCare, LLC in 2006, and at Cygnus, Inc., a drug delivery and specialty pharmaceuticals company. Mr. Dasu holds a B.E. in Chemical Engineering from the University of Mangalore, India and a M.S. in Chemical Engineering from the University of Tulsa.

Basic Compensation

Total Annual Compensation, USD 1,071,840
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 7,800
Fiscal Year Total, USD 1,079,640

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --